Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Lugar:
Miami, FL | 15/08/2026 19:08:58 PM | Salario: S/. No Especificado | Empresa:
PharvarisPharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Lugar:
Seattle, WA | 06/08/2026 02:08:43 AM | Salario: S/. $160000 - 185000 per year | Empresa:
PharvarisPharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Lugar:
Denver, CO | 06/08/2026 02:08:46 AM | Salario: S/. $160000 - 185000 per year | Empresa:
PharvarisPharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Lugar:
Detroit, MI | 06/08/2026 01:08:21 AM | Salario: S/. $160000 - 185000 per year | Empresa:
PharvarisPharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Lugar:
Chicago, IL | 06/08/2026 01:08:36 AM | Salario: S/. $160000 - 185000 per year | Empresa:
PharvarisPharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists..., oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention...